Article info
PDFPoster presentations
P60 Ustekinumab is an effective drug for steroid-free remission in children with refractory IBD and anti TNF-alpha induced psoriasis
Citation
P60 Ustekinumab is an effective drug for steroid-free remission in children with refractory IBD and anti TNF-alpha induced psoriasis
Publication history
- First published April 28, 2021.
Online issue publication
April 28, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.